Could an antibody boost chemo for tough blood cancers?
NCT ID NCT07072585
First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This large clinical trial is testing whether adding the drug daratumumab to standard chemotherapy helps children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL). Daratumumab is an antibody that targets a protein on cancer cells, helping the immune system attack them. The study will compare event-free survival between those who get chemo alone and those who get chemo plus daratumumab.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Daratumumab (a monoclonal antibody) added to standard chemotherapy
- What this could lead to
- If successful, this could lead to a more effective first-line treatment for T-ALL and T-LL, potentially improving long-term survival rates.
- What could go wrong
- This is a large but still experimental trial. Daratumumab may not improve outcomes over chemotherapy alone, and side effects from adding it could be significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personalized chemo dosing may boost survival in kids with High-Risk leukemia
- Engineered immune cells take aim at Hard-to-Treat T-Cell cancers
- Engineered immune cells take aim at stubborn blood cancers
- Double-Barreled immune attack aims to wipe out T-ALL
- Chemotherapy showdown: which combo works best for T-Cell cancers in kids?
- Gene test spots hidden leukemia in kids